Transplantation: Clinical Trials

9 trials for Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 1 terminated, 1 withdrawn. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 4, Unknown 3, Terminated 1, Withdrawn 1

Follow Transplantation: new trials by email Literature Review of Transplantation trials Research Report on Transplantation

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision Medicine Offers Belatacept Monotherapy
Belatacept - Transplantation
Phase 4WithdrawnUniversity of California, San Francisco2019-02-012022-12-06
Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation
Tacrolimus monohydrate (ADOPORT®) - Transplantation, Kidney
Phase 4CompletedUniversity Hospital, Limoges302018-02-122025-07-20
Low-dose IL-2 for Treg Expansion and Tolerance (LITE)
IL-2 (interleukin 2) - Transplantation, Liver Diseases
Phase 4TerminatedKing's College London62017-12-122019-08-14
Adjuvanted Influenza Vaccine in Stem Cell Transplant
FLUAD® influenza vaccine, FLUVIRAL® - Transplantation, Influenza Vaccines
Phase 4CompletedUniversity Health Network, Toronto732015-10-012017-04-10
Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS
Mycophenolate sodium, Pantoprazole, Mycophenolate mofetil - Transplantation, Immunosuppression
Phase 4CompletedKlemens Budde202012-01-012019-02-21
Fibrosis in Renal Allografts
sirolimus, cyclosporine, daclizumab - Kidney Failure, Chronic, Transplantation
Phase 4UnknownUniversity Hospital, Antwerp1002005-05-012008-11-26
Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
tacrolimus - Kidney Transplantation, Transplantation
Phase 4CompletedJanssen-Cilag Pty Ltd892004-05-012011-06-20
Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
sirolimus, cyclosporine, tacrolimus - Transplantation, Kidney Transplantation
Phase 4UnknownNational Taiwan University Hospital402002-09-012005-09-14
The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
sirolimus, cyclosporine, tacrolimus - Transplantation, Kidney Transplantation
Phase 4UnknownNational Taiwan University Hospital402002-03-012005-09-14

Narrower conditions

Bronchiolitis Obliterans Syndrome (1)  ·  Influenza, Human (1)  ·  Kidney Failure, Chronic (1)  ·  Liver Diseases (1)  ·  Pulmonary Fibrosis (1)  ·  Renal Insufficiency (1)

Broader conditions

Respiratory Tract Diseases (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Lung Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Chronic Disease (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)

Interventions

Cyclosporine (3)  ·  Sirolimus (3)  ·  Tacrolimus (3)  ·  Abatacept (1)  ·  Daclizumab (1)  ·  Influenza Vaccines (1)  ·  Interleukin-2 (1)  ·  Mycophenolic Acid (1)  ·  Pantoprazole (1)  ·  aldesleukin (1)

Sponsors

National Taiwan University Hospital (2)  ·  Janssen-Cilag Pty Ltd (1)  ·  King's College London (1)  ·  Klemens Budde (1)  ·  University Health Network, Toronto (1)  ·  University Hospital, Antwerp (1)  ·  University Hospital, Limoges (1)  ·  University of California, San Francisco (1)

Countries

Taiwan (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Alberto Sanchez-Fueyo (1)  ·  Deepali Kumar, MD (1)  ·  Flavio Vincenti, MD (1)  ·  Jean-Louis Bosmans, M.D. Ph.D. (1)  ·  Klemens Budde, Prof Dr (1)  ·  Pierre Marquet, MD (1)  ·  Po-Huang Lee (1)  ·  Po-Huang Lee, MD PhD (1)

Results publications

PMID 10221490, PMID 10798738, PMID 12438948, PMID 12761269, PMID 15660173, PMID 15899725, PMID 19670189, PMID 21040167, PMID 33230714, PMID 36087863

NIH funding

2004 (1)